09639400600

Saturday To Thursday 9 am To 6 pm
butwwbuttw

Popular Pharmaceuticals Ltd.

  Latest
Alarup

Alarup

Alarup..

Tk.10.00/=

  0 отзывов

Alcadin E/D

Alcadin E/D

Alcadin E/D..

Tk.400.00/=

  0 отзывов

Amlovas 5 mg Tablet

Amlovas 5 mg Tablet

Amlovas 5 mg Tablet..

Tk.5.00/=

  0 отзывов

Amlovas VS 5/160 Tablet

Amlovas VS 5/160 Tablet

Amlovas VS 5/160 Tablet..

Tk.16.25/=

  0 отзывов

Amlovas VS 5/80 Tab

Amlovas VS 5/80 Tab

Amlovas VS 5/80 Tab..

Tk.9.00/=

  0 отзывов

Anorel Oin

Anorel Oin

Anorel Oin..

Tk.80.30/=

  0 отзывов

Aquafresh Liquigel E/D

Aquafresh Liquigel E/D

Aquafresh Liquigel E/D..

Tk.270.00/=

  0 отзывов

Avona 8

Avona 8

Avona 8..

Tk.10.00/=

  0 отзывов

Avona Oral Solution

Avona Oral Solution

Avona Oral Solution..

Tk.35.00/=

  0 отзывов

Benozol E/D

Benozol E/D

Benozol E/D..

Tk.500.00/=

  0 отзывов

Besibac E/D

Besibac E/D

Besibac E/D..

Tk.350.00/=

  0 отзывов

Betacor 2.5Mg Tab

Betacor 2.5Mg Tab

Betacor 2.5Mg Tab..

Tk.6.00/=

  0 отзывов

Brimopres E/D

Brimopres E/D

Brimopres E/D..

Tk.120.42/=

  0 отзывов

Cefobac 250

Cefobac 250

Cefobac 250..

Tk.25.09/=

  0 отзывов

Cefobac 500 Tab

Cefobac 500 Tab

Cefobac 500 Tab..

Tk.45.12/=

  0 отзывов

Cefobac 70 ml

Cefobac 70 ml

Cefobac 70 ml..

Tk.198.75/=

  0 отзывов

Cefomin 100

Cefomin 100

Cefomin 100..

Tk.20.00/=

  0 отзывов

Clavurox 500

Clavurox 500

Clavurox 500..

Tk.50.00/=

  0 отзывов

Clavurox PFS 70ml

Clavurox PFS 70ml

Clavurox PFS 70ml..

Tk.252.00/=

  0 отзывов

Clonapin 0.5mg tab

Clonapin 0.5mg tab

Clonapin 0.5mg tab..

Tk.5.00/=

  0 отзывов

Clonapin 2 mg Tab

Clonapin 2 mg Tab

Clonapin 2 mg Tab..

Tk.8.00/=

  0 отзывов

Domilux 10mg Tab

Domilux 10mg Tab

Domilux 10mg Tab..

Tk.2.00/=

  0 отзывов

doxofyl 400 mg tab

doxofyl 400 mg tab

doxofyl 400 mg tab..

Tk.10.00/=

  0 отзывов

Glucosal

Glucosal

Glucosal..

Tk.101.20/=

  0 отзывов

Glucosal M

Glucosal M

Glucosal M..

Tk.94.08/=

  0 отзывов

Hypophos 667 mg Tablet

Hypophos 667 mg Tablet

Hypophos 667 mg Tablet..

Tk.5.52/=

  0 отзывов

Lindac 100mg Tab

Lindac 100mg Tab

Lindac 100mg Tab..

Tk.5.02/=

  0 отзывов

M-Lucas 10mg Tab

M-Lucas 10mg Tab

M-Lucas 10mg Tab..

Tk.15.00/=

  0 отзывов

M-Lucas 4mg Tab

M-Lucas 4mg Tab

M-Lucas 4mg Tab..

Tk.6.00/=

  0 отзывов

M-Lucas 5mg Tab

M-Lucas 5mg Tab

M-Lucas 5mg Tab..

Tk.8.00/=

  0 отзывов

Metarin 500 mg Tablet

Metarin 500 mg Tablet

Metarin 500 mg Tablet..

Tk.4.00/=

  0 отзывов

Methox 2.5

Methox 2.5

Methox 2.5..

Tk.5.52/=

  0 отзывов

Mometa Cream

Mometa Cream

Mometa Cream..

Tk.180.00/=

  0 отзывов

Mylofen 10mg Tab

Mylofen 10mg Tab

Mylofen 10mg Tab..

Tk.8.00/=

  0 отзывов

Mylofen 5mg Tab

Mylofen 5mg Tab

Mylofen 5mg Tab..

Tk.4.45/=

  0 отзывов

Nitrovas SR 2.6

Nitrovas SR 2.6

Nitrovas SR 2.6..

Tk.4.02/=

  0 отзывов

Optafenac TS E/D

Optafenac TS E/D

Optafenac TS E/D..

Tk.225.00/=

  0 отзывов

Optavit Cap

Optavit Cap

Optavit Cap..

Tk.10.00/=

  0 отзывов

Orbidex E/D

Orbidex E/D

Orbidex E/D..

Tk.70.00/=

  0 отзывов

Orbidex G E/D

Orbidex G E/D

Orbidex G E/D..

Tk.120.00/=

  0 отзывов

Orbidex T E/D

Orbidex T E/D

Orbidex T E/D..

Tk.150.00/=

  0 отзывов

P- Dol Tab

P- Dol Tab

P- Dol Tab..

Tk.50.00/=

  0 отзывов

P-Dol tab

P-Dol tab

P-Dol tab..

Tk.5.00/=

  0 отзывов

Pantogut 20 Tab

Pantogut 20 Tab

Pantogut 20 Tab..

Tk.5.00/=

  0 отзывов

Patadin DS E/D

Patadin DS E/D

Patadin DS E/D..

Tk.175.00/=

  0 отзывов

Preclot 75 mg Tablet

Preclot 75 mg Tablet

Preclot 75 mg Tablet..

Tk.12.00/=

  0 отзывов

Pyrostig

Pyrostig

Pyrostig..

Tk.25.09/=

  0 отзывов

Rosu 10 mg Tablet

Rosu 10 mg Tablet

Rosu 10IndicationRosuvastatin is indicated for: Patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non HDL-C and TG levels and to increase HDL-C.Patients with hypertriglyceredemia as an adjunct to diet.Patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet.Patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB.Slowing the progression of atherosclerosis as part of a treatment strategy to lower total-C and LDL-C as an adjunct to diet.Pediatric patients 10 to 17 years of age with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated total-C, LDL-C and ApoB after failing an adequate trial of diet therapy.Risk reduction of Myocardial Infarction (MI), stroke and arterial revascularization procedures in patients without clinically evident CHD, but with multiple risk factors.Dosage & AdministrationGeneral Dosing Information:The dose range for Rosuvastatin is 5 to 40 mg orally once daily. The usual starting dose is 10-20 mg. Rosuvastatin can be administered as a single dose at any time of day, with or without food. When initiating Rosuvastatin therapy or switching from another HMG-CoA reductase inhibitor therapy, the appropriate Rosuvastatin starting dose should first be utilized, and only then titrated according to the patient`s response and individualized goal of therapy. After initiation or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and the dosage adjusted accordingly. The 40 mg dose of Rosuvastatin should be used only for those patients who have not achieved their LDL-C goal utilizing the 20 mg dose.Heterozygous Familial Hypercholesterolemia in PediatricPatients (10 to 17 years of age): The usual dose range of Rosuvastatin is 5- 20 mg/day; the maximum recommended dose is 20 mg/day (doses greater than 20 mg have not been studied in this patient population). Doses should be individualized according to the recommended goal of therapy. Adjustments should be made atintervals of 4 weeks or more.PrecautionsRosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age >65 years, inadequately treated hypothyroidism, renal impairment). The risk of myopathy during treatment with Rosuvastatin may be increased with concurrent administration of some other lipid-lowering therapies (Fibrates or Niacin), Gemfibrozil, Cyclosporine, Lopinavir/Ritonavir, or Atazanavir/Ritonavir. Rosuvastatin therapy should be discontinued if markedly elevated creatinine kinase levels occur or myopathy is diagnosed or suspected. Rosuvastatin therapy should also be temporarily withheld in any patient with an acute, serious condition suggestive of myopathy or predisposing to the development of renal failure secondary to rhabdomyolysis (e.g., sepsis, hypotension, dehydration, major surgery, trauma, severe metabolic, endocrine, and electrolyte disorders, or uncontrolled seizures). It is recommended that liver enzyme tests be performed before and at 12 weeks following both the initiation of therapy and any elevation of dose, and periodically (e.g., semiannually) thereafter...

Tk.18.00/=

  0 отзывов

Rosu 20 mg Tablet

Rosu 20 mg Tablet

Rosu 20IndicationRosuvastatin is indicated for: Patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non HDL-C and TG levels and to increase HDL-C.Patients with hypertriglyceredemia as an adjunct to diet.Patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet.Patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB.Slowing the progression of atherosclerosis as part of a treatment strategy to lower total-C and LDL-C as an adjunct to diet.Pediatric patients 10 to 17 years of age with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated total-C, LDL-C and ApoB after failing an adequate trial of diet therapy.Risk reduction of Myocardial Infarction (MI), stroke and arterial revascularization procedures in patients without clinically evident CHD, but with multiple risk factors.Dosage & AdministrationGeneral Dosing Information:The dose range for Rosuvastatin is 5 to 40 mg orally once daily. The usual starting dose is 10-20 mg. Rosuvastatin can be administered as a single dose at any time of day, with or without food. When initiating Rosuvastatin therapy or switching from another HMG-CoA reductase inhibitor therapy, the appropriate Rosuvastatin starting dose should first be utilized, and only then titrated according to the patient`s response and individualized goal of therapy. After initiation or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and the dosage adjusted accordingly. The 40 mg dose of Rosuvastatin should be used only for those patients who have not achieved their LDL-C goal utilizing the 20 mg dose.Heterozygous Familial Hypercholesterolemia in PediatricPatients (10 to 17 years of age): The usual dose range of Rosuvastatin is 5- 20 mg/day; the maximum recommended dose is 20 mg/day (doses greater than 20 mg have not been studied in this patient population). Doses should be individualized according to the recommended goal of therapy. Adjustments should be made atintervals of 4 weeks or more.PrecautionsRosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age >65 years, inadequately treated hypothyroidism, renal impairment). The risk of myopathy during treatment with Rosuvastatin may be increased with concurrent administration of some other lipid-lowering therapies (Fibrates or Niacin), Gemfibrozil, Cyclosporine, Lopinavir/Ritonavir, or Atazanavir/Ritonavir. Rosuvastatin therapy should be discontinued if markedly elevated creatinine kinase levels occur or myopathy is diagnosed or suspected. Rosuvastatin therapy should also be temporarily withheld in any patient with an acute, serious condition suggestive of myopathy or predisposing to the development of renal failure secondary to rhabdomyolysis (e.g., sepsis, hypotension, dehydration, major surgery, trauma, severe metabolic, endocrine, and electrolyte disorders, or uncontrolled seizures). It is recommended that liver enzyme tests be performed before and at 12 weeks following both the initiation of therapy and any elevation of dose, and periodically (e.g., semiannually) thereafter...

Tk.30.00/=

  0 отзывов

Rosu 5 mg Tablet

Rosu 5 mg Tablet

Rosu 5 mg TabletIndicationRosuvastatin is indicated for: Patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non HDL-C and TG levels and to increase HDL-C.Patients with hypertriglyceredemia as an adjunct to diet.Patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet.Patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB.Slowing the progression of atherosclerosis as part of a treatment strategy to lower total-C and LDL-C as an adjunct to diet.Pediatric patients 10 to 17 years of age with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated total-C, LDL-C and ApoB after failing an adequate trial of diet therapy.Risk reduction of Myocardial Infarction (MI), stroke and arterial revascularization procedures in patients without clinically evident CHD, but with multiple risk factors.Dosage & AdministrationGeneral Dosing Information:The dose range for Rosuvastatin is 5 to 40 mg orally once daily. The usual starting dose is 10-20 mg. Rosuvastatin can be administered as a single dose at any time of day, with or without food. When initiating Rosuvastatin therapy or switching from another HMG-CoA reductase inhibitor therapy, the appropriate Rosuvastatin starting dose should first be utilized, and only then titrated according to the patient`s response and individualized goal of therapy. After initiation or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and the dosage adjusted accordingly. The 40 mg dose of Rosuvastatin should be used only for those patients who have not achieved their LDL-C goal utilizing the 20 mg dose.Heterozygous Familial Hypercholesterolemia in PediatricPatients (10 to 17 years of age): The usual dose range of Rosuvastatin is 5- 20 mg/day; the maximum recommended dose is 20 mg/day (doses greater than 20 mg have not been studied in this patient population). Doses should be individualized according to the recommended goal of therapy. Adjustments should be made atintervals of 4 weeks or more.PrecautionsRosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age >65 years, inadequately treated hypothyroidism, renal impairment). The risk of myopathy during treatment with Rosuvastatin may be increased with concurrent administration of some other lipid-lowering therapies (Fibrates or Niacin), Gemfibrozil, Cyclosporine, Lopinavir/Ritonavir, or Atazanavir/Ritonavir. Rosuvastatin therapy should be discontinued if markedly elevated creatinine kinase levels occur or myopathy is diagnosed or suspected. Rosuvastatin therapy should also be temporarily withheld in any patient with an acute, serious condition suggestive of myopathy or predisposing to the development of renal failure secondary to rhabdomyolysis (e.g., sepsis, hypotension, dehydration, major surgery, trauma, severe metabolic, endocrine, and electrolyte disorders, or uncontrolled seizures). It is recommended that liver enzyme tests be performed before and at 12 weeks following both the initiation of therapy and any elevation of dose, and periodically (e.g., semiannually) thereafter...

Tk.10.00/=

  0 отзывов

Showing 1 to 50 of 76 (2 Pages)